Clinical trials open for recruitment

The following clinical trials are in the process of recruiting participants. Some of the recruitment pathways for these trials are open to the public while others require a specialist referral. Please click on the trial links below to find out more information and register your interest.

Cardiology - Detecting Early Risk of Heart Failure in Saliva - CLEER

Detecting Early Risk of Heart Failure in Saliva (CLEER)
Coeliac Disease and Immune Health - Gluten Threshold Study

A Double-Blind, Placebo-Controlled, Adaptive Dose-Response Study To Assess the Acute Effects of Gluten in Adults with Treated Coeliac Disease
Coeliac Disease and Immune Health - Dental Enamel Defects Study

Evaluating the prevalence of Coeliac Disease in children with Developmental Defects of Enamel
Emerald - Younger Women's Wellness After Cancer Study

A study to pilot an Australian lifestyle intervention in younger women. The intervention aims to improve health and wellness in younger women after treatment for cancer.
Neurology - Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)

A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients with C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD).
Neurology - Parkinson’s Disease, Dementia with Lewy Bodies (DLB), or Mild Cognitive Impairment (MCI)

A Phase II, Randomised, Placebo-Controlled, Double-Blind, Crossover, Study of the Pharmacodynamic Effects of CST-103 co-administered with CST-107 on the Central Nervous System in Subjects with Neurodegenerative Disorders
Neurology - Tourette's Syndrome

An open-label, Phase IIa, Multicentre, 12-week prospective study to evaluate the safety and efficacy of NOE-105 at a daily dose range of 5mg to 15mg in adult male patients with Tourette's Syndrome.
Neurology - Tranexamic Acid (TXA) Dosing in Primary Total Knee Arthroplasty

A Prospective, Randomised Non-Blinded Pilot Study to Optimise Oral Tranexamic Acid Dosing in Primary Total Knee Arthroplasty
Rare Diseases - Immunoglobulin G4 (IgG4) Related Disease

A Phase 3, Randomised, Double-blind, Multicentre, Placebo-Controlled Study of Inebilizumab Efficacy and Safety in Immunoglobulin G4-related disease (IgG4) Related Disease (MITIGATE).

What do clinical trials mean to the families of participants?

Related news

Amanda’s Story

Amanda’s Story Flashback to the middle of 2019, it was just like any other normal day at work for Amanda,...

Melanies Story: Tourette Syndrome Awareness Week

Melanies Story: Tourette Syndrome Awareness Week Melanie, whose name has been changed to protect her privacy, is a young woman...

Clinical Trial Gives Hope to the 1 in 7 Australian Coeliac Sufferers

Clinical Trial Gives Hope to the 1 in 7 Australian Coeliac Sufferers Coeliac sufferers might not have to cut gluten...

Rare Disease Clinical Trial Gives Families Hope for the Future

Rare Disease Clinical Trial Gives Families Hope for the Future Now in the Courier Mail (click the above image to...

Clinical trials open for recruitment

Clinical trials open for recruitment